Cited by 532SARS-CoV-2 and COVID-19 ResearchCOVID-19 Clinical Research StudiesPluripotent Stem Cells Research

The DOI matches its Crossref record; 33 of the 33 references it cites were found in a registry or an index.

Identification of SARS-CoV-2 inhibitors using lung and colonic organoids

Open access

Han, Yuling, Duan, Xiaohua, Yang, Liuliu, Nilsson-Payant, Benjamin E., Wang, Pengfei, Duan, Fuyu, Tang, Xuming, Yaron, Tomer M., Zhang, Tuo, Uhl, Skyler, Bram, Yaron, Richardson, Chanel, Zhu, Jiajun, Zhao, Zeping, Redmond, David, Houghton, Sean, Nguyen, Duc-Huy T., Xu, Dong, Wang, Xing, Jessurun, Jose, Borczuk, Alain, Huang, Yaoxing, Johnson, Jared L., Liu, Yuru, Xiang, Jenny, Wang, Hui, Cantley, Lewis C., tenOever, Benjamin R., Ho, David D., Pan, Fong Cheng, Evans, Todd, Chen, Huanhuan Joyce, Schwartz, Robert E., Chen, Shuibing·2021·Nature

DOI 10.1038/s41586-020-2901-9PMC PMC8034380

Open this paper in CoChat — free account Open PDF

Abstract

There is an urgent need to create novel models using human disease-relevant cells to study severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) biology and to facilitate drug screening. Here, as SARS-CoV-2 primarily infects the respiratory tract, we developed a lung organoid model using human pluripotent stem cells (hPSC-LOs). The hPSC-LOs (particularly alveolar type-II-like cells) are permissive to SARS-CoV-2 infection, and showed robust induction of chemokines following SARS-CoV-2 infection, similar to what is seen in patients with COVID-19. Nearly 25% of these patients also have gastrointestinal manifestations, which are associated with worse COVID-19 outcomes 1. We therefore also generated complementary hPSC-derived colonic organoids (hPSC-COs) to explore the response of colonic cells to SARS-CoV-2 infection. We found that multiple colonic cell types, especially enterocytes, express ACE2 and are permissive to SARS-CoV-2 infection. Using hPSC-LOs, we performed a high-throughput screen of drugs approved by the FDA (US Food and Drug Administration) and identified entry inhibitors of SARS-CoV-2, including imatinib, mycophenolic acid and quinacrine dihydrochloride. Treatment at physiologically relevant levels of these drugs significantly inhibited SARS-CoV-2 infection of both hPSC-LOs and hPSC-COs. Together, these data demonstrate that hPSC-LOs and hPSC-COs infected by SARS-CoV-2 can serve as disease models to study SARS-CoV-2 infection and provide a valuable resource for drug screening to identify candidate COVID-19 therapeutics.

The claims and statistics of this paper haven’t been checked yet.

Run the check — free, no account needed. It reads the open-access text and checks the sources it cites.

Integrity signals

Registry

Crossref · 10.1038/s41586-020-2901-9

Cites

33 of 33 references verified0 citation errors · 0 not checkable

Statistics

Claims the paper makes

The claims and statistics of this paper haven’t been checked yet.

Run the check — free, no account needed. It reads the open-access text and checks the sources it cites.

Claims other papers make about this one

Each is checked against this paper’s own text: does it say what the citing paper says it does?

Self-check

Percentages, sums and reported differences re-computed from the paper’s own numbers.

The self-check needs the paper’s full text.

<tt>edgeR</tt> : a Bioconductor package for differential expression analysis of digital gene expression data
Robinson, M. D., McCarthy, D. J., & Smyth, G. K. (2010) · Bioinformatics · doi:10.1093/bioinformatics/btp616 · Cited by 41,364
SARS-CoV-2 Cell Entry Depends on ACE2 and TMPRSS2 and Is Blocked by a Clinically Proven Protease Inhibitor
Hoffmann, M., Kleine-Weber, H., Schroeder, S., Krüger, N., Herrler, T., Erichsen, S., Schiergens, T. S., Herrler, G., Wu, N.-H., Nitsche, A., et al. (2020) · Cell · doi:10.1016/j.cell.2020.02.052 · Cited by 20,286
Comprehensive Integration of Single-Cell Data
Stuart, T., Butler, A., Hoffman, P., Hafemeister, C., Papalexi, E., Mauck, W. M., Hao, Y., Stoeckius, M., Smibert, P., & Satija, R. (2019) · Cell · doi:10.1016/j.cell.2019.05.031 · Cited by 15,453
A SARS-CoV-2 protein interaction map reveals targets for drug repurposing
Gordon, D. E., Jang, G. M., Bouhaddou, M., Xu, J., Obernier, K., White, K. M., O’Meara, M. J., Rezelj, V. V., Guo, J. Z., Swaney, D. L., et al. (2020) · Nature · doi:10.1038/s41586-020-2286-9 · Cited by 4,405
Self-citation
Imbalanced Host Response to SARS-CoV-2 Drives Development of COVID-19
Blanco-Melo, D., Nilsson-Payant, B. E., Liu, W.-C., Uhl, S., Hoagland, D., Møller, R., Jordan, T. X., Oishi, K., Panis, M., Sachs, D., et al. (2020) · Cell · doi:10.1016/j.cell.2020.04.026 · Cited by 4,222
Self-citation
WebGestalt 2019: gene set analysis toolkit with revamped UIs and APIs
Liao, Y., Wang, J., Jaehnig, E. J., Shi, Z., & Zhang, B. (2019) · Nucleic Acids Research · doi:10.1093/nar/gkz401 · Cited by 3,144
Cell entry mechanisms of SARS-CoV-2
Shang, J., Wan, Y., Luo, C., Ye, G., Geng, Q., Auerbach, A., & Li, F. (2020) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.2003138117 · Cited by 3,142
Inhibition of SARS-CoV-2 Infections in Engineered Human Tissues Using Clinical-Grade Soluble Human ACE2
Monteil, V., Kwon, H., Prado, P., Hagelkrüys, A., Wimmer, R. A., Stahl, M., Leopoldi, A., Garreta, E., Hurtado del Pozo, C., Prosper, F., et al. (2020) · Cell · doi:10.1016/j.cell.2020.04.004 · Cited by 2,122
Clinical Characteristics of COVID-19 Patients With Digestive Symptoms in Hubei, China: A Descriptive, Cross-Sectional, Multicenter Study
Pan, L., Mu, M., Yang, P., Sun, Y., Wang, R., Yan, J., Li, P., Hu, B., Wang, J., Hu, C., et al. (2020) · American Journal of Gastroenterology · doi:10.14309/ajg.0000000000000620 · Cited by 1,823
A molecular cell atlas of the human lung from single-cell RNA sequencing
Travaglini, K. J., Nabhan, A. N., Penland, L., Sinha, R., Gillich, A., Sit, R. V., Chang, S., Conley, S. D., Mori, Y., Seita, J., et al. (2020) · Nature · doi:10.1038/s41586-020-2922-4 · Cited by 1,730

Show all 33 references

Sorted by citations

Items 401–500 of 532

Organotypic human lung bud microarrays identify BMP-dependent SARS-CoV-2 infection in lung cells
Rosado-Olivieri, E. A., Razooky, B. S., Pen, J. L., Santis, R. D., Barrows, D., Sabry, Z., Hoffmann, H.-H., Park, J., Carroll, T. S., Poirier, J. T., et al. (2023) · Stem Cell Reports · doi:10.1016/j.stemcr.2023.03.015 · Cited by 4
Establishment of a screening platform based on human coronavirus OC43 for the identification of microbial natural products with antiviral activity
Martínez-Arribas, B., Annang, F. B., Díaz-González, R., Pérez‐Moreno, G., Martı́n, J., Mackenzie, T. A., Castillo, F., Reyes, F., Genilloud, O., Ruiz-Pérez, L. M., et al. (2023) · Microbiology Spectrum · doi:10.1128/spectrum.01679-23 · Cited by 4
OrgXenomics: an integrated proteomic knowledge base for patient-derived organoid and xenograft
Zhang, Y., Lian, X., Xu, H., Zhu, S., Zhang, H., Ni, Z., Fu, T., Liu, S., Tao, L., Zhou, Y., et al. (2024) · Nucleic Acids Research · doi:10.1093/nar/gkae861 · Cited by 4
Organoids and Organ-On-Chip Models for COVID-19 Research and Its Application in Modernization of Traditional Chinese Medicine: Opportunities and Challenges
Sheng, H., Liang, Y., Lauschke, V. M., & Wang, Y. (2025) · Engineering · doi:10.1016/j.eng.2025.01.019 · Cited by 5
Quinacrine, an Old Drug with Potentially usefull in the Treatment for COVID-19
Pineda, B. (2021) · Archives of Medical Research · doi:10.1016/j.arcmed.2021.06.002 · Cited by 4
Recent advances in health biotechnology during pandemic
Aslan, A., Alhamwı, S., Kurtur, O. B., GÜNDÜZ, O., Çakan, D., Üstündağ, C. B., Doymuş, B., Topuzoğulları, M., Yilmaz, B. B., Gök, B., et al. (2023) · Sigma Journal of Engineering and Natural Sciences – Sigma Mühendislik ve Fen Bilimleri Dergisi · doi:10.14744/sigma.2023.00065 · Cited by 5
Advances in porcine respiratory and intestinal organoids: status and potential application for virus infections
Liu, C., Dong, X., Liu, P., & Lin, X. (2024) · One Health Advances · doi:10.1186/s44280-024-00052-0 · Cited by 4
[The clinical importance of keratin 18 in breast cancer].
Schaller, G., Fuchs, I., Ebert, A. D., Gstettenbauer, M., Herbst, H., & Lengyel, E. R. (1999) · PubMed · Cited by 4
Druggable redox pathways against M. abscessus in cystic fibrosis patient-derived airway organoidsPreprint
Leon‐Icaza, S. A., Bagayoko, S., Vergé, R., Iakobachvili, N., Ferrand, C., Aydogan, T., Bernard, C., Dafun, A. S., Murris‐Espin, M., Mazières, J., et al. (2022) · bioRxiv (Cold Spring Harbor Laboratory) · doi:10.1101/2022.01.03.474765 · Cited by 4
Animal organoids as transformative platforms for viral infections and zoonotic cross-species viral research
García-Rodríguez, I., García-Dorival, I., Alonso, C., & Cuesta-Geijo, M. Á. (2026) · Journal of Virology · doi:10.1128/jvi.02197-25 · Cited by 3
Targeting the epithelium in pulmonary fibrosis
Lizé, M., Mayr, C. H., Bleck, M., Wollin, L., Wohnhaas, C. T., Shalashova, I., Olbrich, H., Heilker, R., Engler, A., Bammert, M., et al. (2026) · European Respiratory Review · doi:10.1183/16000617.0225-2025 · Cited by 3
High-Throughput Screening for the Potential Inhibitors of SARS-CoV-2 with Essential Dynamic Behavior
Yang, Z., Zhang, L., Cai, X., Ye, Q., Zhao, Y., Li, X., & Zhang, S. (2023) · Current Drug Targets · doi:10.2174/1389450124666230306141725 · Cited by 3
Organoids in COVID-19: can we break the glass ceiling?
Chau, C. W., & Sugimura, R. (2023) · Journal of Leukocyte Biology · doi:10.1093/jleuko/qiad098 · Cited by 3
A prospects tool in virus research: Analyzing the applications of organoids in virus studies
Shen, Q., Zhou, Y., & Zhou, Y.-Q. (2024) · Acta Tropica · doi:10.1016/j.actatropica.2024.107182 · Cited by 3
Tissue-specific decellularized extracellular matrix rich in collagen, glycoproteins, and proteoglycans and its applications in advanced organoid engineering: A review
Cui, X., Liu, H., Liu, Y., Yu, Z., Wang, D., Wei, W., & Wang, S. (2025) · International Journal of Biological Macromolecules · doi:10.1016/j.ijbiomac.2025.144469 · Cited by 5
Self-citation
Repurposing antitumor drugs for the treatment of non-oncological diseases: Mechanistic insights, clinical evidence, and future perspectives
Zhu, L., Li, Z., Yuan, Z., Li, H., Zhou, T., Chen, Y., & Zhang, L. (2025) · Biochemical Pharmacology · doi:10.1016/j.bcp.2025.117118 · Cited by 3
Synergistic Action of Immunotherapy and Nanotherapy against Cancer Patients Infected with SARS-CoV-2 and the Use of Artificial Intelligence
Gupta, T., Debele, T. A., Wei, Y., Gupta, A., Murtaza, M., & Su, W. (2022) · Cancers · doi:10.3390/cancers14010213 · Cited by 3
Cinnamon: an immune modulator food additive to coronavirus
Verma, R., & Bisen, P. S. (2022) · Journal of Food Bioactives · doi:10.31665/jfb.2022.17298 · Cited by 3
Emerging toolset of three-dimensional pulmonary cell culture models for simulating lung pathophysiology towards mechanistic elucidation and therapeutic treatment of SARS-COV-2 infection
Ni, K., Che, B., Yang, C., Qin, Y., Gu, R., Wang, C., Luo, M., & Deng, L. (2022) · Frontiers in Pharmacology · doi:10.3389/fphar.2022.1033043 · Cited by 3
Sulforaphane’s Nuclear Factor Erythroid 2-Related Factor 2 (Nrf2)-Dependent and -Independent Mechanism of Anti-SARS-CoV-2 Activity
Yan, Z., Liang, W., Zhu, L., Kreso, I., Romero, V., Smith, M., & Chen, Y. (2024) · Journal of Respiratory Biology and Translational Medicine · doi:10.35534/jrbtm.2024.10010 · Cited by 3
Targeting protein homeostasis with small molecules as a strategy for the development of pan-coronavirus antiviral therapies
Mao, Y.-Q., Jahanshahi, S., Malty, R. H., Ommen, D. A. J. V., Wan, Y., Morey, T. M., Chuang, S. H. W., Pavlova, V., Ahmed, C., Dahal, S., et al. (2024) · Communications Biology · doi:10.1038/s42003-024-07143-z · Cited by 3
Lysosomal “TRAP”: a neotype modality for clearance of viruses and variants
Lyu, C., He, Z., Hu, X., Wang, S., Qin, M., Zhu, L., Li, Y., Yang, F., Jiao, Z., Zhang, X., et al. (2024) · Nature Communications · doi:10.1038/s41467-024-54505-6 · Cited by 4
Induced pluripotent stem cell–based tissue models to study malaria: a new player in the research game
Korbmacher, F., & Bernabeu, M. (2025) · Current Opinion in Microbiology · doi:10.1016/j.mib.2025.102585 · Cited by 3
Landscape of Molecular Crosstalk Perturbation between Lung Cancer and COVID-19
Kuchi, A., Wu, J., Fuloria, J., & Hicks, C. (2022) · International Journal of Environmental Research and Public Health · doi:10.3390/ijerph19063454 · Cited by 3
Coiled-coil lipopeptides mediated membrane fusion based drug delivery into a mimicking lung organ
Wang, X., Wan, W., Liu, G., Ren, T., Thomas, J. O., Wu, H., An, C., Tian, F., Zhu, Y., Kros, A., et al. (2025) · Chemical Engineering Journal · doi:10.1016/j.cej.2025.163333 · Cited by 2
Self-citation
Vasostatin-2 attenuates injury-induced neointimal hyperplasia through the ACE2/MasR/PPARγ/NR1D1/Gas1 axis
Chen, Q., Liu, J., Madonna, R., Li, F., Chen, S., Li, L., Wu, X., Maimati, Y., Ding, F., Wang, X., et al. (2025) · Cardiovascular Research · doi:10.1093/cvr/cvaf192 · Cited by 2
Self-citation
Tropism, replication competence, and cellular responses of HAdV-14p1 in human airway organoids
Guo, W., Yang, Y., Liang, Y., Cui, F., Li, L., Peng, X., Zhou, J., Li, Y., Deng, Y., Wang, Y., et al. (2025) · iScience · doi:10.1016/j.isci.2025.114323 · Cited by 2
Recent Advancements in the Generation and Application of Therapeutic Cell Populations for Lung Epithelial Repair
Zhou, M., Brinson, D., Lei, C., & Karoubi, G. (2025) · Journal of Tissue Engineering and Regenerative Medicine · doi:10.1155/term/8367426 · Cited by 2
In silico assessment of cyanobacterial alkaloids as probable medications against SARS-CoV-2
Sen, A., Chanda, H. M. K. C., Cheemanapalli, S., Umamaheswari, A., Rath, J., & Joardar, N. (2026) · In Silico Research in Biomedicine · doi:10.1016/j.insi.2026.100215 · Cited by 2
Disease modeling and drug screening using human airway organoids: a systematic review
Kim, D. H., & Kim, S. W. (2021) · Organoid · doi:10.51335/organoid.2021.1.e8 · Cited by 2
Host‐modifying drugs against COVID ‐19: some successes, but not yet the breakthrough
Brüssow, H. (2021) · Environmental Microbiology · doi:10.1111/1462-2920.15828 · Cited by 2
Comments on ‘An airway organoid-based screen identifies a role for the HIF1α‒glycolysis axis in SARS-CoV-2 infection’
Duan, X., Wang, H., Ho, D. D., Schwartz, R. E., Evans, T., & Chen, S. (2021) · Journal of Molecular Cell Biology · doi:10.1093/jmcb/mjab075 · Cited by 2
Self-citation
Stress granule formation as a marker of cellular toxicity in lung organoids
Kim, S.-Y., Kim, K. K., & Kim, E. (2022) · Organoid · doi:10.51335/organoid.2022.2.e28 · Cited by 3
Multi-omics characterization of RNA binding proteins reveals disease comorbidities and potential drugs in COVID-19
Pan, J., Gao, Y., Han, H., Pan, T., Guo, J., Li, S., Xu, J., & Li, Y. (2023) · Computers in Biology and Medicine · doi:10.1016/j.compbiomed.2023.106651 · Cited by 2
Human Organoids, their Perspective, and Applications for Personalized Therapy: Rapid Review
Pratap, P. D., & Ahmad, S. (2023) · Global Journal of Medical Pharmaceutical and Biomedical Update · doi:10.25259/gjmpbu_96_2022 · Cited by 2
Tissue-Engineered Three-Dimensional Platforms for Disease Modeling and Therapeutic Development
Wheeler, E. E., & Leach, J. K. (2024) · Tissue Engineering Part B Reviews · doi:10.1089/ten.teb.2024.0212 · Cited by 3
SCovid v2.0: a comprehensive resource to decipher the molecular characteristics across tissues in COVID-19 and other human coronaviruses
Zhu, Z., Chen, X., He, G., Yu, R., Wang, C., Qi, C., & Cheng, L. (2024) · Microbiology Spectrum · doi:10.1128/spectrum.01933-24 · Cited by 2
Organoids in host pathology: Unveiling microbial-induced therapeutic responses
Sun, L., Duan, Y., Lan, Q., Wang, Y., Wong, A. S. T., Ni, Y., & Liu, D. (2025) · Microbiological Research · doi:10.1016/j.micres.2025.128313 · Cited by 2
SARS-CoV-2-Infektion des Verdauungstrakts – Experimentelle Ansätze einer Organoid-basierten in vitro Modellierung
Hentschel, V., Groß, R. M., Krüger, J., Münch, J., Müller, M., & Kleger, A. (2021) · Zeitschrift für Gastroenterologie · doi:10.1055/a-1500-8420 · Cited by 2
SARS–CoV–2 and Food—How Confident Are We about Them?
Economou, V., Sakkas, H., Bezirtzoglou, E., Papa, A., & Soultos, N. (2021) · Hygiene · doi:10.3390/hygiene1030008 · Cited by 2
Learning from cancer to address COVID-19
Oláh, E. (2023) · Biologia Futura · doi:10.1007/s42977-023-00156-5 · Cited by 2
Integrated Transcriptomic Analysis Reveals Reciprocal Interactions between SARS-CoV-2 Infection and Multi-Organ Dysfunction, Especially the Correlation of Renal Failure and COVID-19
Li, P., Liu, M., & He, W.-M. (2024) · Life · doi:10.3390/life14080960 · Cited by 2
Different kinds of stem cells in the development of SARS-CoV-2 treatments
Mata-Miranda, M. M., Sánchez-Brito, M., & Vázquez-Zapién, G. J. (2021) · World Journal of Stem Cells · doi:10.4252/wjsc.v13.i5.439 · Cited by 2
An iTSC-derived placental model of SARS-CoV-2 infection reveals ACE2-dependent susceptibility in syncytiotrophoblastsPreprint
Chen, J., Neil, J. A., Tan, J., Rudraraju, R., Mohenska, M., Sun, Y., Sun, G., Zhou, Y., Li, Y., Drew, D. R., et al. (2021) · bioRxiv (Cold Spring Harbor Laboratory) · doi:10.1101/2021.10.27.465224 · Cited by 2
COVID cure or perpetual vaccination?: 30 cheap effective treatments of COVID-19 & variants, like ivermectin, or never-ending compulsory injection, with unsafe, genotoxic, infertilizing, injuring, crippling, handicapping, lethal, inefficient, ineffective, abortion-tainted, abortive, unethical, experimental genetic-hacks, deceivingly called vaccines instead of haccines? Scientific proof of the COVID PLANdemic with 2000 peer reviewed published references.Preprint
Nazar, F. A. (2021) · Thesis Commons (OSF Preprints) · doi:10.31237/osf.io/trz5s · Cited by 2
NF-κB inhibitor alpha has a cross-variant role during SARS-CoV-2 infection in ACE2-overexpressing human airway organoidsPreprint
Simoneau, C. R., Chen, P., Xing, G. K., Khalid, M. M., Meyers, N. L., Hayashi, J. M., Taha, T. Y., Leon, K. E., Ashuach, T., Fontaine, K. A., et al. (2022) · bioRxiv (Cold Spring Harbor Laboratory) · doi:10.1101/2022.08.02.502100 · Cited by 2
Cell culture models for SARS-CoV-2 infectivity and systemic complications
Sa‐ngiamsuntorn, K., Thongsri, P., Pewkliang, Y., & Wongkajornsilp, A. (2022) · Pharmaceutical Sciences Asia · doi:10.29090/psa.2022.04.22.058 · Cited by 1
Exploring the potential of organoids in advancing disease modeling for viral diseases
Hu, X., Zhou, L., Wang, X., Jiang, J., An, S., Ye, L., & Liang, H. (2024) · Future Virology · doi:10.1080/17460794.2024.2400823 · Cited by 1
Self-citation
Patient-derived induced pluripotent stem cell organoids for amyotrophic lateral sclerosis drug discovery
Li, W., Liu, J., Li, W., Sun, L., Zhang, H., Gao, L., & Gao, C. (2025) · Acta Materia Medica · doi:10.15212/amm-2024-0077 · Cited by 1
Engineering the Micro‐Nano Hierarchical Spray Hydrogel for Acute Lung Injury Therapy
Xu, Y., Zhao, R., Xi, P., Xu, C., Yang, M., Che, J., Gu, Z., & Zhu, Y. (2025) · Advanced Healthcare Materials · doi:10.1002/adhm.202500114 · Cited by 1
Coculture of tumor organoids with pathogenic microorganisms: a novel system to mimic in vivo pathogenic infection
Zhang, X., Sun, S., Cheng, S., Dai, J., Du, F., Wang, J., Wei, D., Yan, Y., & Liu, Y. (2025) · Frontiers in Cellular and Infection Microbiology · doi:10.3389/fcimb.2025.1601688 · Cited by 1
Self-citation
A human intestinal organoid derived from fetal human colon cells model for studying enteroviral pathogenesis
Li, C., Chen, Y., Zhou, X., Lin, J., & Luo, Z. (2025) · Virulence · doi:10.1080/21505594.2025.2542455 · Cited by 1
Research insights and clinical opportunities of functional organoid-based platforms
Huang, Y., Shen, W., Li, K., Zhang, Y., Lv, Q., Wang, C., Mao, W., & Zhao, A. (2025) · Bio-Design and Manufacturing · doi:10.1631/bdm.2400519 · Cited by 1
Self-citation
Organoid application in virology research: Recent progress and emerging directions
Sheng, W., Wang, H., & LI, Y. (2026) · Infectious Diseases & Immunity · doi:10.1097/id9.0000000000000203 · Cited by 1
Self-citation
Organoids: From Bench to Bedside Applications
Li, K., Cao, R., Li, M., Tian, Z., Fan, H., Hong, B., & Liu, X. (2026) · MedComm · doi:10.1002/mco2.70768 · Cited by 1
Human heart valve-like tissues from pluripotent stem cells with enhanced maturation recapitulate inflammatory valve disease
Voges, H. K., Durrant-Whyte, J., See, M., Iaprintsev, V., Yeow, S., Parker, B. L., Bibby, K., Keen, E., King, I., Piers, A. T., et al. (2026) · Cell stem cell · doi:10.1016/j.stem.2026.07.010 · Cited by 1
Human Stem Cell Models of SARS-CoV-2 Infection in the Cardiovascular System
Ernzen, K., Trask, A. J., Peeples, M. E., Garg, V., & Zhao, M. (2021) · Stem Cell Reviews and Reports · doi:10.1007/s12015-021-10229-4 · Cited by 1
Corona virus, origin and disease characteristics till cell therapy by mesenchymal stem cells and exosomes: a gate for an effective therapeutic strategies
Amini, E., Mohammadi, P., Eslami, K., Shafizadeh, A., Mousavi Befrouei, Z. S., Allahgholi, A., & Fallah, S. (2021) · Cell & Tissue Journal · doi:10.52547/jct.12.4.233 · Cited by 1
"Potential Antiviral Drug for the Treatment of SARS- CoV-2 Based on Quinacrine and Porous Silicon"
Sattorov, M. S. (2022) · Biomedical Journal of Scientific & Technical Research · doi:10.26717/bjstr.2022.42.006735 · Cited by 1
Ex situ-armus: experimental models for combating respiratory dysfunction
Varankar, S., Cardoso, E. C., & Lee, J. (2022) · Current Opinion in Genetics & Development · doi:10.1016/j.gde.2022.101946 · Cited by 1
Human Maternal-Fetal Interface Cellular Models to Assess Antiviral Drug Toxicity during Pregnancy
Herbek, S. L., Smithgall, M. C., Murphy, E. A., Schwartz, R. E., Chen, S., Riley, L. E., Stuhlmann, H., Yang, Y. J., & Goswami, R. (2022) · Reproductive Medicine · doi:10.3390/reprodmed3040024 · Cited by 1
Self-citation
Transcriptome profiling of different types of human respiratory tract cells infected by SARS-CoV-2 highlight an unique role for inflammatory and interferon response
Yang, M., Lei, L., Cao, Q., Yang, Y., Wang, J., Jiang, X., Huang, K., Lai, J., Qing, L., Wang, Y., et al. (2021) · All Life · doi:10.1080/26895293.2021.1879280 · Cited by 1
Self-citation
Application of Cell Culture Models in Studying Viral Diseases (SARS, H1N1 Flu, MERS, COVID-19): A Review
Hadjizadeh, A., Alavi, M., Tajvar, S., & Hadjizadeh, A. (2021) · Journal of Integrative Cardiology Open Access · doi:10.31487/j.jicoa.2021.03.07 · Cited by 1
Organoids: a new research model for SARS-CoV-2infection and treatment
Wang, T., Fan, S., & Chen, Y. (2021) · Scientia Sinica Vitae · doi:10.1360/ssv-2021-0294 · Cited by 1
Genomics-led insight into the coronavirus evolution, pathogenicity and management
Farwaha, N., Das, H., Saikia, R., Paswan, R. R., Phukon, M., Baruah, R. R., Kalita, R., Bhorali, P., Borah, B. K., & Nathh, T. (2021) · Annals of Phytomedicine An International Journal · doi:10.54085/ap.covid19.2021.10.2.10 · Cited by 1
Unpacking COVID-19 Systems Biology in Lung and Whole Blood with Transcriptomics and miRNA Regulators
Anatolou, D., Dovrolis, N., Ragia, G., Kolios, G. C., & Manolopoulos, V. G. (2022) · OMICS A Journal of Integrative Biology · doi:10.1089/omi.2022.0104 · Cited by 1
Organoids-on-a-chip
Yaqing, W. A. N. G., Tao, T., & Qin, J. (2022) · Scientia Sinica Vitae · doi:10.1360/ssv-2022-0027 · Cited by 1
Organoid research in China
Chen, Y., & Zhao, L. (2023) · Scientia Sinica Vitae · doi:10.1360/ssv-2023-0004 · Cited by 1
Síndrome Respiratória Aguda Grave por COVID-19: Perfil Clínico-Epidemiológico e Distribuição Espacial dos Óbitos nas Unidades Federativas do Brasil
de Oliveira, R. A., Neto, M. S., Pascoal, L. M., Bezerra, J. M., Santos, F. S., Brito, P. D. S., & de Sousa, G. G. D. S. (2022) · O Mundo da Saúde · doi:10.15343/0104-7809.202246620635p · Cited by 1
Self-organized stem cell-derived human lung buds with proximo-distal patterning and novel targets of SARS-CoV-2Preprint
Rosado-Olivieri, E. A., Razooky, B. S., Hoffmann, H.-H., Santis, R. D., Rice, C. M., & Brivanlou, A. H. (2021) · bioRxiv (Cold Spring Harbor Laboratory) · doi:10.1101/2021.01.06.425622 · Cited by 1
Science’s Response to COVID-19Preprint
Aye, Y., & Long, M. J. C. (2021) · Preprints.org · doi:10.20944/preprints202103.0416.v1 · Cited by 1
Arrayed multicycle drug screens identify broadly acting chemical inhibitors for repurposing against SARS-CoV-2Preprint
Murer, L., Volle, R., Andriasyan, V., Meili, N., Yang, L., Sequeira, D. P., Gómez-González, A., Petkidis, A., Olszewski, D., Bauer, M., et al. (2021) · bioRxiv (Cold Spring Harbor Laboratory) · doi:10.1101/2021.03.30.437771 · Cited by 1
Self-citation
Editorial: 3D organoid and organ-on-a-chip and their applications for virology and antiviral research
Yin, Y., Xu, L., & Steinway, S. N. (2023) · Frontiers in Microbiology · doi:10.3389/fmicb.2023.1266136 · Cited by 1
A Human Alveolus-on-Chip Recapitulates SARS-CoV-2-mediated Lung Injury in an Organ-relevant Context for Pre-clinical ApplicationsPreprint
Kiener, M., Maddalena, L. L. D., Roldán, N., Chouvardas, P., Froment, L., Menna, M. D., Geiser, T., Stucki, J. D., Hobi, N., & Julio, M. K. (2025) · bioRxiv (Cold Spring Harbor Laboratory) · doi:10.1101/2025.10.17.683096 · Cited by 1
A community effort to discover small molecule SARS-CoV-2 inhibitorsPreprint
Schimunek, J., Seidl, P., Elez, K., Hempel, T., Le, T., Noé, F., Olsson, S., Raich, L., Winter, R., Gökcan, H., et al. (2023) · ChemRxiv · doi:10.26434/chemrxiv-2023-1d5w8 · Cited by 1
Treatment of Covid-19 with Minocycline and a Guanosine-Restricted Diet: Case ReportPreprint
Baranowitz, S. A., & Nrekaj, M. (2020) · Preprints.org · doi:10.20944/preprints202012.0596.v1
Self-Organizing, Symmetry Breaking, Isogenic Human Lung Buds on Microchips Identify Alveolar Stem Cells as Novel Targets of SARS-CoV-2Preprint
Rosado-Olivieri, E. A., Razooky, B. S., Hoffmann, H.-H., Santis, R. D., Rice, C. M., & Brivanlou, A. H. (2021) · SSRN Electronic Journal · doi:10.2139/ssrn.3773794
Single-cell transcriptomics of lung organoids
Song, Y. N., & Lee, M. R. (2021) · Organoid · doi:10.51335/organoid.2021.1.e9
The ground truth of the Data-Iceberg: Correct Meta-dataPreprint
Caliskan, A., Dangwal, S., & Dandekar, T. (2021) · bioRxiv · doi:10.1101/2021.12.17.473021
Lung Organoid: Innovative Technology for Respiratory Disease Modelling
Halim, N. S. S. A., Shaffie, S. A. C., Patar, M. N. A. A., & Yahaya, B. H. (2022) · Stem cell biology and regenerative medicine · doi:10.1007/978-3-030-93056-1_3
Lung Organoids: A New Pathway into Lung Regeneration and Repair
Tian, L., Zhang, C. C., Rea-Moreno, M., & Chen, Y. (2022) · Stem cell biology and regenerative medicine · doi:10.1007/978-3-030-93056-1_2
Modelling of a wide variety of disease using adult stem cell-derived organoids
van der Vaart, J. Y. (2022) · Utrecht University Repository (Utrecht University) · doi:10.33540/930
Role of Functional Food Additives in Regulating the Immune Response to COVID-19
Verma, R., & Bagel, M. P. (2022) · Current Biotechnology · doi:10.2174/2211550111666220613143422
Understanding the cellular pathogenesis of COVID-19 symptoms using organoid technology
Che, Y. H., & Kim, Y. J. (2022) · Organoid · doi:10.51335/organoid.2022.2.e16
Effects of coronavirus disease 19 on the gastrointestinal tract and the potential impact on gastrointestinal toxicities during cancer treatment
Stringer, A. M. (2022) · Current Opinion in Supportive and Palliative Care · doi:10.1097/spc.0000000000000604
SARS-CoV-2 Infection of Lung Organoids Reveals Conserved Use of Tetraspanin-8 by Ancestral-, Delta-, and Omicron- VariantsPreprint
Hysenaj, L., Little, S., Kulhanek, K. R., Magnen, M., Bahl, K., Gbenedio, O. M., Prinz, M., Rodriguez, L., Andersen, C., Rao, A. A., et al. (2022) · SSRN Electronic Journal · doi:10.2139/ssrn.4198511
Evaluation of the gut microbiota patterns in patients with COVID-19: a protocol for a pilot studyPreprint
Nejadghaderi, S. A., Mojarad, E. N., Fazlollahi, A., Pirsadeghi, A., Khalili, A., & Rezaei, N. (2022) · Research Square · doi:10.21203/rs.3.rs-2323771/v1
Severe Acute Respiratory Syndrome by COVID-19: Clinical-Epidemiological Profile and Spatial Distribution of Deaths in the States of Brazil
de Oliveira, R. A., Neto, M. S., Pascoal, L. M., Bezerra, J. M., Santos, F. S., Brito, P. D. S., & de Sousa, G. G. D. S. (2022) · O Mundo da Saúde · doi:10.15343/0104-7809.202246620635i
Application of new technologies in embryos: From gene editing to synthetic embryos
Martin‐Inaraja, M., Romayor, I., Herrera, L., Montserrat, N., & Eguizábal, C. (2023) · Elsevier eBooks · doi:10.1016/b978-0-323-91380-5.00032-0
Ex Vivo Drug Testing of Patient-Derived Lung Organoids to Predict Treatment Responses for Personalized MedicinePreprint
Hung, C., Williams, M., Williams, R., Chen, M., Kamali, S., Sambandam, V., Chiu, C. H.-L., Osmulski, P. A., Gaczynska, M. E., DeArmond, D. T., et al. (2023) · Preprints.org · doi:10.20944/preprints202306.1176.v1
Application of iPS Cells to Human Lung Disease Research
Gotoh, S. (2022) · Nihon Naika Gakkai Zasshi · doi:10.2169/naika.111.1439
Breathing life into in vitro models
Baptista, D. (2023) · Research Publications (Maastricht University) · doi:10.26481/dis.20231003db
Organoides de origen humano como modelo fisiopatológico de evaluación terapéutica de fármacos en COVID-19
Weinstein, C., González-López, E., Bahamondez‐Canas, T., Campos‐Estrada, C., & Moraga-Espinoza, D. (2023) · ARS MEDICA Revista de Ciencias Médicas · doi:10.11565/arsmed.v48i3.1986
Modeling Lung Development and Diseases with Lung OrganoidsPreprint
Zhou, L., Liu, D., Wei, J., Zhu, X., & Jiang, L. (2023) · SSRN Electronic Journal · doi:10.2139/ssrn.4581586
Diverse Cellular Tropisms and Immune Responses during Beta-Coronavirus Infections in Human Bronchial Epithelial OrganoidsPreprint
Choi, Y. K., Park, D., Kim, S., Jang, H. B., Kim, K., Ji, H. Y., Yang, H., Kwon, W., Kang, Y.-L., Hwang, S., et al. (2023) · Research Square · doi:10.21203/rs.3.rs-3391310/v1
Mapping the scientific output of organoids for modeling animal and human infectious diseases: A bibliometric assessmentPreprint
Jin, Y., Cougoule, C., Lacroix‐Lamandé, S., & Wiedemann, A. (2023) · Research Square · doi:10.21203/rs.3.rs-3691844/v1
The Role of Changes in Structure and Dynamics of Chromatin due to COVID-19
Bigildeev, A., Alekseev, V. I., Gribkova, A. K., Timokhin, G. S., Komarova, G. A., & Shaytan, A. К. (2024) · Russian Journal of Genetics · doi:10.1134/s1022795424010034
Organoids in Antiviral Research: Potential and Challenges
Singh, A., Kumar, N., Desai, D. N., Sahu, U., Bhatia, S., Kumar, M., Tripathi, B. N., & Sanyal, A. (2024) · Livestock diseases and management · doi:10.1007/978-981-99-9195-2_4
The gut microbiota patterns of patients with COVID-19: protocol for a case-control study
Nejadghaderi, S. A., Mojarad, E. N., Fazlollahi, A., Pirsadeghi, A., Khalili, A., Ebrahimi, R., & Rezaei, N. (2024) · Translational Medicine Communications · doi:10.1186/s41231-024-00177-9
Host- and genomics-based antiviral approaches
Mostafa, A., Khalil, A. M., Hegazy, A., Mahmoud, S. H., & Martínez‐Sobrido, L. (2024) · Elsevier eBooks · doi:10.1016/b978-0-443-18866-4.00010-9

Authors: Han, Y., Duan, X., Yang, L., Nilsson-Payant, B. E., Wang, P., Duan, F., Tang, X., Yaron, T. M., Zhang, T., Uhl, S., Bram, Y., Richardson, C., Zhu, J., Zhao, Z., Redmond, D., Houghton, S., Nguyen, D.-H. T., Xu, D., Wang, X., Jessurun, J., Borczuk, A., Huang, Y., Johnson, J. L., Liu, Y., Xiang, J., Wang, H., Cantley, L. C., tenOever, B. R., Ho, D. D., Pan, F. C., Evans, T., Chen, H. J., Schwartz, R. E., & Chen, S.
Affiliations: Weill Cornell Medicine (US)
Shanghai Jiao Tong University (CN)
Icahn School of Medicine at Mount Sinai (US)
Aaron Diamond AIDS Research Center (US)
University of Chicago (US)
University of Illinois Chicago (US)
Corresponding author: Wang, Hui
Cantley, Lewis C.
tenOever, Benjamin R.
Ho, David D.
Pan, Fong Cheng
Evans, Todd
Chen, Huanhuan Joyce
Schwartz, Robert E.
Chen, Shuibing
ORCID: Han, Yuling
Duan, Xiaohua
Yang, Liuliu
Nilsson-Payant, Benjamin E.
Wang, Pengfei
Duan, Fuyu
Tang, Xuming
Yaron, Tomer M.
Zhang, Tuo
Uhl, Skyler
Bram, Yaron
Zhu, Jiajun
Redmond, David
Houghton, Sean
Nguyen, Duc-Huy T.
Xu, Dong
Wang, Xing
Jessurun, Jose
Borczuk, Alain
Huang, Yaoxing
Johnson, Jared L.
Liu, Yuru
Xiang, Jenny
Wang, Hui
Cantley, Lewis C.
tenOever, Benjamin R.
Ho, David D.
Pan, Fong Cheng
Evans, Todd
Chen, Huanhuan Joyce
Schwartz, Robert E.
Chen, Shuibing
Venue: Nature
Publisher: Springer Science and Business Media LLC
Published: 2020-10-28
Volume: 589
Issue: 7841
Pages: 270-275
ISSN: 0028-0836 (ISSN-L)
1476-4687
DOI: 10.1038/s41586-020-2901-9
PMC: PMC8034380
OpenAlex: W3096177766
Cited by: 530
References: 33
Citations by year: 2026: 35 · 2025: 51 · 2024: 67 · 2023: 94 · 2022: 120 · 2021: 155 · 2020: 7
FWCI: 12.35
Type: journal article
Language: en
Update notices: correction (2024-05-29)
Open access: bronze
doi.org
Licence: www.springernature.com/gp/researchers/text-and-data-mining (tdm)
www.springernature.com/gp/researchers/text-and-data-mining (vor)
Locations: Nature (publishedVersion)
PubMed (publishedVersion)
PubMed Central (acceptedVersion)
RePEc: Research Papers in Economics (submittedVersion)
Funders: American Diabetes Association (7-20-COVID-211)
Icahn School of Medicine at Mount Sinai
Nature
National Institutes of Health
Defense Advanced Research Projects Agency (W911NF‐16‐C‐0050)
Weill Cornell Medical College
Advanced Research Projects Agency
National Cancer Institute (R00CA226353, R01CA234614)
National Institute of Allergy and Infectious Diseases (R01AI107301)
National Institute of Diabetes and Digestive and Kidney Diseases (R01DK124463, R01DK116075, R01DK119667, 1RO3DK117252, R01DK121072, DP3DK111907, R03DK117252)
Topics: Health Sciences › Medicine › Infectious Diseases › SARS-CoV-2 and COVID-19 Research
Health Sciences › Medicine › Infectious Diseases › COVID-19 Clinical Research Studies
Life Sciences › Biochemistry, Genetics and Molecular Biology › Molecular Biology › Pluripotent Stem Cells Research
Keywords: SARS-CoV-2, COVID-19 pandemic, lung organoids, colonic organoids, human pluripotent stem cells, alveolar type II cells, enterocytes, ACE2 expression, entry inhibitors, imatinib, mycophenolic acid, high-throughput drug screening, FDA-approved drugs, antiviral activity, chemokine induction, gastrointestinal manifestations of COVID-19
MeSH terms: COVID-19, SARS-CoV-2, COVID-19 Drug Treatment, Animals, Antiviral Agents, Colon, Drug Evaluation, Preclinical, Female, Humans, Lung, Male, Organoids, United States, United States Food and Drug Administration, Drug Approval, Mice, Virus Internalization, Viral Tropism, Heterografts, In Vitro Techniques

About these checks

Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.

Statistics and arithmetic are recomputed, not judged.

Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.

What counts as a claim ›How we measure confidence ›How we check this ›

Are you an author, or do you see a problem with this page? Request a review

Identification of SARS-CoV-2 inhibitors using lung and colonic organoids

Abstract

Overview

Integrity signals

Verification

Claims the paper makes

Claims other papers make about this one

Self-check

Citations

Cites

Cited by

Related

Metadata

Record

About these checks